Regenxbio (RGNX) Retained Earnings (2014 - 2026)

Regenxbio's Retained Earnings history runs 12 years deep, the most recent figure standing at -$687000.0 for Q4 2025.

• In Q4 2025, Retained Earnings rose 7.29% year-over-year to -$687000.0; the TTM figure through Dec 2025 stood at -$687000.0 (up 7.29% YoY), while the FY2025 annual figure was -$687000.0, up 7.29% from the prior year.
• Retained Earnings for Q4 2025 stood at -$687000.0, down from -$652000.0 in the prior quarter.
• The five-year high for Retained Earnings was -$652000.0 in Q3 2025, with the low at -$996.9 million in Q2 2025.
• The 5-year median for Retained Earnings is -$389.2 million (2021), against an average of -$360.1 million.
• The sharpest annual moves came in 2021 and 2025: Retained Earnings plunged 53020.0% in 2021, then soared 99.93% in 2025.
• Regenxbio's Retained Earnings stood at -$2.6 million in 2021, then tumbled by 17087.74% to -$441.6 million in 2022, then tumbled by 59.67% to -$705.0 million in 2023, then soared by 99.89% to -$741000.0 in 2024, then increased by 7.29% to -$687000.0 in 2025.
• Business Quant data shows RGNX's Retained Earnings at -$687000.0 in Q4 2025, -$652000.0 in Q3 2025, and -$996.9 million in Q2 2025.